CIDRAP's May 6 analysis of The Lancet letter on US measles elimination remains the operative frame: the United States is highly likely to lose its elimination status in November, with 24 new outbreaks in 2026, 93% of cases outbreak-associated, and four of seven CDC elimination indicators already missed. [1] The paper's May 19 major on the case counter and the November PAHO review as the two operational instruments made the same point, and nothing in this week's news has moved either dial.

The denominator held. CBS Atlanta's same-week story added three confirmed cases in a metro Atlanta family — local texture, not a CDC update. [2] No new weekly federal print has bumped the working figure past last edition's number, and the kindergarten-MMR rate remains below the 95% needed for herd immunity. [1]

The November clock also held. The Pan American Health Organization Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission will decide the country's status in the fall, and no public-health body announced a procedural change this week. [1] The transmission rate stayed above 1 for most of the past year, which is what "ongoing transmission" actually means in the elimination criteria. [1]

For families, the unchanged instruments do not mean a quiet week — they mean the same week, again. A two-dose MMR remains the cheapest piece of preparedness in the medicine cabinet. The November review will read the count it inherits.

-- NORA WHITFIELD, Chicago